Free Trial

Cingulate (CINGW) Competitors

$0.08 +0.01 (+8.41%)
As of 01/17/2025 03:49 PM Eastern

CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Cingulate vs.

180 Life Sciences (NASDAQ:ATNFW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings.

180 Life Sciences and Cingulate both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
CingulateN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Cingulate tied by winning 0 of the 0 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$176.09M$5.23B$8.94B
Dividend YieldN/A3.64%5.13%4.04%
P/E RatioN/A133.2058.7713.30
Price / SalesN/A18,796.851,253.7679.32
Price / CashN/A13.0143.8235.97
Price / BookN/A9.535.324.79
Net IncomeN/A-$20.89M$122.69M$225.00M
7 Day PerformanceN/A-0.62%-0.17%1.52%
1 Month PerformanceN/A1.66%3.49%4.88%
1 Year PerformanceN/A130.31%25.79%20.12%

Cingulate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.08
+8.4%
N/A+396.3%$0.00N/A0.0020Positive News
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+3.0%
N/A+80.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-7.3%
N/A+30.9%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.19
+11.8%
N/AN/A$0.00$40,633.000.0040News Coverage
Positive News
Gap Down
ALVOW
Alvotech
N/A$3.06
-7.3%
N/A+25.4%$0.00$391.87M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
-23.5%
N/A+78.6%$0.00N/A0.004Gap Up
BFRIW
Biofrontera
N/A$0.09
+1.4%
N/A+687.9%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.41
-16.3%
N/AN/A$0.00$193.06M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.18
+11.6%
N/A-93.5%$0.00N/A0.008Short Interest ↑
News Coverage
Positive News
Gap Down
CELUW
Celularity
N/A$0.03
-1.8%
N/AN/A$0.00$48.20M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:CINGW) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners